<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190130042555N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-05-21</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effects of active distraction and Shen Men point massage on pain and anxiety during venipuncture in children 4-7 year old</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effects of active distraction and Shen Men point massage on pain and anxiety during venipuncture in children 4-7 year old hospitalized</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-05-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>144</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88962</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Sampling and Randomization

Initially, all hospitalized children aged 4–7 years who met the inclusion criteria were stratified based on age (4–5 years and 6–7 years) and gender (female/male) in order to balance the distribution of these potential confounding variables across the study groups. Within each stratum, a list of eligible children was prepared, and a unique numerical code was assigned to each child.

For randomization, a random allocation list for the three groups (active distraction group, Shen Men point massage group, and control group) was prepared in advance by an individual independent of the sampling process using a random numbers table (or computer‑generated random numbers). In this list, the allocation sequence of participants to the three groups was arranged using random blocks of equal size (e.g., blocks of six) to ensure that the number of participants in each group remained approximately equal.

When each eligible child entered the study, the researcher responsible for data collection assigned the participant to one of the three groups according to the predetermined allocation sequence and the order of enrollment, without any personal judgment or interference. In this way, the likelihood of allocation bias was minimized and the principle of randomization was maintained in the study, Blinding description: The study will be single-blind, meaning that the statistician will not know the type of intervention in the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain.</hc_freetext>
      <i_freetext>Intervention 1: intervention Group:In the active distraction group, after providing an introduction, explaining the study objectives, and obtaining informed consent from the parents and the child, the child—accompanied by the mother—is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and free of additional stimuli). First, the Piyeri Anxiety Scale is completed by an assessor.Three semi-prepared cartoon animal templates (such as lion, rabbit, and elephant), designed based on psychological principles of visual attractiveness, along with accessories such as stickers, child-safe scissors, and colored pencils, are provided to the mother and child. They are given 5 minutes to collaboratively complete and personalize the chosen figure. The researcher actively assists the mother and child during this stage.The completed figure is then gently attached to the IV catheter cover to serve as an engaging visual element. The cover, now decorated with the figure, is handed to the child to hold and interact with during venipuncture.Immediately afterward, venipuncture is performed by a trained and experienced nurse who has not previously met the child during hospitalization and has been instructed to maintain consistent behavior with all participants. During catheter insertion, pain intensity is assessed using the Wong-Baker Visual Analog Scale, and anxiety levels are assessed using the Facial Anxiety Scale by an independent assessor who has been previously trained in scoring and evaluation.Immediately after venipuncture, the Piyeri Anxiety Scale is administered again and recorded by the assessor. Finally, the decorated figure is placed on the IV dressing after the procedure is completed. Intervention 2: Intervention Group: Acupressure GroupAfter introducing the study, explaining its objectives, and obtaining informed consent from the parents and the child to participate in the research, the child, accompanied by the mother, is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and free from additional stimuli). First, the Piyeri Anxiety Scale is measured by the assessor.In the presence of the mother, Shen Men point massage is performed by the researcher on the hand opposite to the venipuncture site for five minutes. The massage procedure is conducted as follows: the child lies on the bed, the researcher first washes and warms their hands, then stands beside the child’s bed, applies baby oil to their hands, and performs circular massage on the Shen Men point in a clockwise direction with moderate pressure.The maximum continuous massage duration is one minute, followed by a ten‑second pause. This cycle continues until the completion of venipuncture. After five minutes from the start of the massage, venipuncture is performed by a trained and experienced nurse who has not previously met the child during hospitalization and has been instructed to maintain consistent behavior during venipuncture with all children.During the insertion of the intravenous catheter, pain intensity is recorded using the Wong–Baker Visual Analog Scale, and anxiety levels are assessed using the Facial Anxiety Scale by an assessor who has been previously trained in the assessment and scoring procedures. Immediately after the completion of venipuncture, the Piyeri Anxiety Scale is measured again by the assessor and recorded. Intervention 3: Control GroupAfter introducing the study, explaining its objectives, and obtaining informed consent from the parents and the child to participate in the research, the child, accompanied by the mother, is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and without additional stimuli). First, the Piyeri Anxiety Scale is administered by the assessor.Children in this group receive only the routine care of the ward. Venipuncture is then performed by the same skilled nurse, who has not previously seen the child during hospitalization and has been trained to maintain consistent behavior during venipuncture with all participants.During insertion of the intravenous catheter, pain intensity is assessed using the Wong–Baker Visual Analog Scale, anxiety is assessed using the Facial Anxiety Scale, and heart rate is recorded by an assessor who has been previously trained in assessment and scoring procedures. Immediately after completion of the venipuncture, the Piyeri Anxiety Scale is administered again by the assessor and recorded.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Taybeh Hassan Tehrani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Sciences, Shahid Fahmideh Blvd., Pazhohesh Square, Hamadan, Iran</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۵۱۷۸۳۸۷۳۶</zip>
        <telephone>+98 81 3838 0150</telephone>
        <email>t.tehrani@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Taybeh Hassan Tehrani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Sciences, Shahid Fahmideh Blvd., Pazhohesh Square, Hamadan, Iran</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۵۱۷۸۳۸۷۳۶</zip>
        <telephone>+98 81 3838 0150</telephone>
        <email>t.tehrani@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Hospitalized child 4 to 7 years old (48 to 83 months)
Having healthy organs and skin in the hand
Do not use painkillers for at least 3 hours before venipuncture.
The child's first hospitalization
Second experience of venipuncture during hospitalization
Has not had a traumatic venipuncture and has only had one previous successful venipuncture
Have informed consent to undergo the procedure
At least 24 hours have passed since the child was hospitalized.</inclusion_criteria>
      <agemin>4 years</agemin>
      <agemax>7 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Failure to obtain a vein the first time
Aggravation of the child's condition</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute pain, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>intervention Group:In the active distraction group, after providing an introduction, explaining the study objectives, and obtaining informed consent from the parents and the child, the child—accompanied by the mother—is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and free of additional stimuli). First, the Piyeri Anxiety Scale is completed by an assessor.Three semi-prepared cartoon animal templates (such as lion, rabbit, and elephant), designed based on psychological principles of visual attractiveness, along with accessories such as stickers, child-safe scissors, and colored pencils, are provided to the mother and child. They are given 5 minutes to collaboratively complete and personalize the chosen figure. The researcher actively assists the mother and child during this stage.The completed figure is then gently attached to the IV catheter cover to serve as an engaging visual element. The cover, now decorated with the figure, is handed to the child to hold and interact with during venipuncture.Immediately afterward, venipuncture is performed by a trained and experienced nurse who has not previously met the child during hospitalization and has been instructed to maintain consistent behavior with all participants. During catheter insertion, pain intensity is assessed using the Wong-Baker Visual Analog Scale, and anxiety levels are assessed using the Facial Anxiety Scale by an independent assessor who has been previously trained in scoring and evaluation.Immediately after venipuncture, the Piyeri Anxiety Scale is administered again and recorded by the assessor. Finally, the decorated figure is placed on the IV dressing after the procedure is completed.</i_keyword>
      <i_keyword>Intervention Group: Acupressure GroupAfter introducing the study, explaining its objectives, and obtaining informed consent from the parents and the child to participate in the research, the child, accompanied by the mother, is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and free from additional stimuli). First, the Piyeri Anxiety Scale is measured by the assessor.In the presence of the mother, Shen Men point massage is performed by the researcher on the hand opposite to the venipuncture site for five minutes. The massage procedure is conducted as follows: the child lies on the bed, the researcher first washes and warms their hands, then stands beside the child’s bed, applies baby oil to their hands, and performs circular massage on the Shen Men point in a clockwise direction with moderate pressure.The maximum continuous massage duration is one minute, followed by a ten‑second pause. This cycle continues until the completion of venipuncture. After five minutes from the start of the massage, venipuncture is performed by a trained and experienced nurse who has not previously met the child during hospitalization and has been instructed to maintain consistent behavior during venipuncture with all children.During the insertion of the intravenous catheter, pain intensity is recorded using the Wong–Baker Visual Analog Scale, and anxiety levels are assessed using the Facial Anxiety Scale by an assessor who has been previously trained in the assessment and scoring procedures. Immediately after the completion of venipuncture, the Piyeri Anxiety Scale is measured again by the assessor and recorded.</i_keyword>
      <i_keyword>Control GroupAfter introducing the study, explaining its objectives, and obtaining informed consent from the parents and the child to participate in the research, the child, accompanied by the mother, is taken to the venipuncture room. The room environment is standardized and calming (with soft lighting and without additional stimuli). First, the Piyeri Anxiety Scale is administered by the assessor.Children in this group receive only the routine care of the ward. Venipuncture is then performed by the same skilled nurse, who has not previously seen the child during hospitalization and has been trained to maintain consistent behavior during venipuncture with all participants.During insertion of the intravenous catheter, pain intensity is assessed using the Wong–Baker Visual Analog Scale, anxiety is assessed using the Facial Anxiety Scale, and heart rate is recorded by an assessor who has been previously trained in assessment and scoring procedures. Immediately after completion of the venipuncture, the Piyeri Anxiety Scale is administered again by the assessor and recorded.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The effect of active distraction on pain intensity. Timepoint: During venipuncture. Method of measurement: Wang Baker Facial Scale.</prim_outcome>
      <prim_outcome>The effect of Shen Men point massage on pain intensity. Timepoint: During venipuncture. Method of measurement: Wang Baker Facial Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The Impact of Shen Men Point Massage on Anxiety Levels. Timepoint: Before, during, and after venipuncture. Method of measurement: Piyeri Anxiety Visual Scale.</sec_outcome>
      <sec_outcome>The Impact of Active Distraction on Anxiety Levels. Timepoint: Before, during, and after venipuncture. Method of measurement: Piyeri Anxiety Visual Scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-24</approval_date>
        <contact_name>Research Ethics Committee of Hamadan University of Medical Scieneces</contact_name>
        <contact_address>Hamadan University of Medical Sciences, Shahid Fahmideh Blvd., Pazhohesh Square, Hamadan, Iran Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
